{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T14:41:04Z","timestamp":1767710464960,"version":"3.48.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"DOI":"10.1007\/s00280-025-04853-x","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T14:39:42Z","timestamp":1767710382000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between modifications in intravenous chemotherapy dose and disease-free survival and related influencing factors in lung cancer patients: a retrospective study based on inverse probability weighting"],"prefix":"10.1007","volume":"96","author":[{"given":"Hangxing","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"issue":"3","key":"4853_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"4853_CR2","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1001\/jamaoncol.2021.4932","volume":"7","author":"AK Ganti","year":"2021","unstructured":"Ganti AK, Klein AB, Cotarla I, Seal B, Chou E (2021) Update of incidence, prevalence, survival, and initial treatment in patients with non-small cell lung cancer in the US. JAMA Oncol 7(12):1824\u20131832. https:\/\/doi.org\/10.1001\/jamaoncol.2021.4932","journal-title":"JAMA Oncol"},{"issue":"4","key":"4853_CR3","doi-asserted-by":"publisher","first-page":"484","DOI":"10.6004\/jnccn.2017.0048","volume":"15","author":"H Reinhardt","year":"2017","unstructured":"Reinhardt H, Trittler R, Eggleton AG et al (2017) Paving the way for dose banding of chemotherapy: an analytical approach. J Natl Compr Canc Netw 15(4):484\u2013493. https:\/\/doi.org\/10.6004\/jnccn.2017.0048","journal-title":"J Natl Compr Canc Netw"},{"issue":"24","key":"4853_CR4","doi-asserted-by":"publisher","first-page":"4524","DOI":"10.1200\/JCO.2003.05.002","volume":"21","author":"GH Lyman","year":"2003","unstructured":"Lyman GH, Dale DC, Crawford J (2003) Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices. J Clin Oncol 21(24):4524\u20134531. https:\/\/doi.org\/10.1200\/JCO.2003.05.002","journal-title":"J Clin Oncol"},{"issue":"8","key":"4853_CR5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrclinonc.2013.108","volume":"10","author":"GH Lyman","year":"2013","unstructured":"Lyman GH, Sparreboom A (2013) Chemotherapy dosing in overweight and obese patients with cancer. Nat Rev Clin Oncol 10(8):451\u2013459. https:\/\/doi.org\/10.1038\/nrclinonc.2013.108","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"4853_CR6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.critrevonc.2010.02.002","volume":"77","author":"H Wildiers","year":"2011","unstructured":"Wildiers H, Reiser M (2011) Relative dose intensity of chemotherapy and its impact on outcomes in patients with early breast cancer or aggressive lymphoma. Crit Rev Oncol Hematol 77(3):221\u2013240. https:\/\/doi.org\/10.1016\/j.critrevonc.2010.02.002","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"4853_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.103449","volume":"9","author":"C Seidel","year":"2024","unstructured":"Seidel C, Schaefers C, Connolly EA et al (2024) Efficacy and safety of high-dose chemotherapy as the first or subsequent salvage treatment line in patients with relapsed or refractory germ cell cancer: an international multicentric analysis. ESMO Open 9(5):103449. https:\/\/doi.org\/10.1016\/j.esmoop.2024.103449","journal-title":"ESMO Open"},{"issue":"4","key":"4853_CR8","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1200\/JCO.2005.03.171","volume":"23","author":"S Singh","year":"2005","unstructured":"Singh S, Parulekar W, Murray N et al (2005) Influence of sex on toxicity and treatment outcome in small-cell lung cancer. J Clin Oncol 23(4):850\u2013856. https:\/\/doi.org\/10.1200\/JCO.2005.03.171","journal-title":"J Clin Oncol"},{"issue":"1","key":"4853_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.6004\/jnccn.2009.0009","volume":"7","author":"GH Lyman","year":"2009","unstructured":"Lyman GH (2009) Impact of chemotherapy dose intensity on cancer patient outcomes. J Natl Compr Canc Netw 7(1):99\u2013108. https:\/\/doi.org\/10.6004\/jnccn.2009.0009","journal-title":"J Natl Compr Canc Netw"},{"key":"4853_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ejphar.2017.05.063","volume":"811","author":"R Oun","year":"2017","unstructured":"Oun R, Rowan E (2017) Cisplatin induced arrhythmia; electrolyte imbalance or disturbance of the SA node? Eur J Pharmacol 811:125\u2013128. https:\/\/doi.org\/10.1016\/j.ejphar.2017.05.063","journal-title":"Eur J Pharmacol"},{"issue":"10","key":"4853_CR11","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1093\/annonc\/mdf249","volume":"13","author":"VC Tjan-Heijnen","year":"2002","unstructured":"Tjan-Heijnen VC, Wagener DJ, Postmus PE (2002) An analysis of chemotherapy dose and dose-intensity in small-cell lung cancer: lessons to be drawn. Ann Oncol 13(10):1519\u20131530. https:\/\/doi.org\/10.1093\/annonc\/mdf249","journal-title":"Ann Oncol"},{"issue":"3","key":"4853_CR12","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1200\/JCO.1991.9.3.499","volume":"9","author":"RJ Klasa","year":"1991","unstructured":"Klasa RJ, Murray N, Coldman AJ (1991) Dose-intensity meta-analysis of chemotherapy regimens in small-cell carcinoma of the lung. J Clin Oncol 9(3):499\u2013508. https:\/\/doi.org\/10.1200\/JCO.1991.9.3.499","journal-title":"J Clin Oncol"},{"issue":"6 Suppl 15","key":"4853_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1053\/j.seminoncol.2004.11.025","volume":"31","author":"J Crawford","year":"2004","unstructured":"Crawford J (2004) The importance of chemotherapy dose intensity in lung cancer. Semin Oncol 31(6 Suppl 15):25\u201331. https:\/\/doi.org\/10.1053\/j.seminoncol.2004.11.025","journal-title":"Semin Oncol"},{"issue":"4","key":"4853_CR14","first-page":"327","volume":"13","author":"PJ Souquet","year":"1996","unstructured":"Souquet PJ, Lombard-Bohas CH, Freyer G, Bombaron P, Geriniere L, Bernard JP (1996) Chemotherapy in elderly patients with bronchogenic cancers. Rev Mal Respir 13(4):327\u2013333","journal-title":"Rev Mal Respir"},{"issue":"9","key":"4853_CR15","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/s0959-8049(99)00029-5","volume":"35","author":"JP Sculier","year":"1999","unstructured":"Sculier JP, Paesmans M, Thiriaux J et al (1999) A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer. European Lung Cancer Working Party. Eur J Cancer 35(9):1314\u20131319. https:\/\/doi.org\/10.1016\/s0959-8049(99)00029-5","journal-title":"Eur J Cancer"},{"issue":"9","key":"4853_CR16","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1097\/JTO.0b013e3181eba7f9","volume":"5","author":"AT Brunetto","year":"2010","unstructured":"Brunetto AT, Carden CP, Myerson J et al (2010) Modest reductions in dose intensity and drug-induced neutropenia have no major impact on survival of patients with non-small cell lung cancer treated with platinum-doublet chemotherapy. J Thorac Oncol 5(9):1397\u20131403. https:\/\/doi.org\/10.1097\/JTO.0b013e3181eba7f9","journal-title":"J Thorac Oncol"},{"issue":"1","key":"4853_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","volume":"11","author":"P Goldstraw","year":"2016","unstructured":"Goldstraw P, Chansky K, Crowley J et al (2016) The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM Classification for Lung Cancer. J Thorac Oncol 11(1):39\u201351. https:\/\/doi.org\/10.1016\/j.jtho.2015.09.009","journal-title":"J Thorac Oncol"},{"issue":"14","key":"4853_CR18","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.3390\/nu14142916","volume":"14","author":"X Li","year":"2022","unstructured":"Li X, Pan Y, Han Y et al (2022) Chinese food image database for eating and appetite studies. Nutrients 14(14):2916. https:\/\/doi.org\/10.3390\/nu14142916","journal-title":"Nutrients"},{"issue":"6","key":"4853_CR19","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649\u2013655","journal-title":"Am J Clin Oncol"},{"issue":"6","key":"4853_CR20","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1213\/ANE.0000000000005773","volume":"133","author":"P Schober","year":"2021","unstructured":"Schober P, Mascha EJ, Vetter TR (2021) Statistics from A (agreement) to Z (z score): a guide to interpreting common measures of association, agreement, diagnostic accuracy, effect size, heterogeneity, and reliability in medical research. Anesth Analg 133(6):1633\u20131641. https:\/\/doi.org\/10.1213\/ANE.0000000000005773","journal-title":"Anesth Analg"},{"issue":"1","key":"4853_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1634\/theoncologist.12-1-79","volume":"12","author":"G Crivellari","year":"2007","unstructured":"Crivellari G, Monfardini S, Stragliotto S, Marino D, Aversa SM (2007) Increasing chemotherapy in small-cell lung cancer: from dose intensity and density to megadoses. Oncologist 12(1):79\u201389. https:\/\/doi.org\/10.1634\/theoncologist.12-1-79","journal-title":"Oncologist"},{"issue":"18","key":"4853_CR22","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1200\/JCO.21.00471","volume":"39","author":"JJ Griggs","year":"2021","unstructured":"Griggs JJ, Bohlke K, Balaban EP et al (2021) Appropriate systemic therapy dosing for obese adult patients with cancer: ASCO guideline update. J Clin Oncol 39(18):2037\u20132048. https:\/\/doi.org\/10.1200\/JCO.21.00471","journal-title":"J Clin Oncol"},{"issue":"12","key":"4853_CR23","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1038\/s41379-018-0110-y","volume":"31","author":"G Rindi","year":"2018","unstructured":"Rindi G, Klimstra DS, Abedi-Ardekani B et al (2018) A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol 31(12):1770\u20131786. https:\/\/doi.org\/10.1038\/s41379-018-0110-y","journal-title":"Mod Pathol"},{"issue":"4","key":"4853_CR24","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/cncr.31124","volume":"124","author":"A Dasari","year":"2018","unstructured":"Dasari A, Mehta K, Byers LA, Sorbye H, Yao JC (2018) Comparative study of lung and extrapulmonary poorly differentiated neuroendocrine carcinomas: a SEER database analysis of 162,983 cases. Cancer 124(4):807\u2013815. https:\/\/doi.org\/10.1002\/cncr.31124","journal-title":"Cancer"},{"key":"4853_CR25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.lungcan.2020.03.008","volume":"143","author":"S Sherman","year":"2020","unstructured":"Sherman S, Rotem O, Shochat T, Zer A, Moore A, Dudnik E (2020) Efficacy of immune check-point inhibitors (ICPi) in large cell neuroendocrine tumors of lung (LCNEC). Lung Cancer 143:40\u201346. https:\/\/doi.org\/10.1016\/j.lungcan.2020.03.008","journal-title":"Lung Cancer"},{"issue":"10","key":"4853_CR26","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/cac2.12359","volume":"42","author":"P Chen","year":"2022","unstructured":"Chen P, Liu Y, Wen Y, Zhou C (2022) Non-small cell lung cancer in China. Cancer Commun 42(10):937\u2013970. https:\/\/doi.org\/10.1002\/cac2.12359","journal-title":"Cancer Commun"},{"issue":"12","key":"4853_CR27","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.2967\/jnumed.118.211102","volume":"59","author":"LM Peterson","year":"2018","unstructured":"Peterson LM, O\u2019Sullivan J, Wu QV et al (2018) Prospective study of serial (18)F-FDG PET and (18)F-Fluoride PET to predict time to skeletal-related events, time to progression, and survival in patients with bone-dominant metastatic breast cancer. J Nucl Med 59(12):1823\u20131830. https:\/\/doi.org\/10.2967\/jnumed.118.211102","journal-title":"J Nucl Med"},{"issue":"12","key":"4853_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189410","volume":"12","author":"ES Kim","year":"2017","unstructured":"Kim ES, Baran AM, Mondo EL et al (2017) Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer. PLoS ONE 12(12):e0189410. https:\/\/doi.org\/10.1371\/journal.pone.0189410","journal-title":"PLoS ONE"},{"key":"4853_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12092493","author":"F Moik","year":"2020","unstructured":"Moik F, van Es N, Posch F et al (2020) Gemcitabine and platinum-based agents for the prediction of cancer-associated venous thromboembolism: results from the Vienna Cancer and Thrombosis Study. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers12092493","journal-title":"Cancers (Basel)"},{"issue":"35","key":"4853_CR30","doi-asserted-by":"publisher","first-page":"4416","DOI":"10.1200\/JCO.2012.42.4358","volume":"30","author":"S Seng","year":"2012","unstructured":"Seng S, Liu Z, Chiu SK et al (2012) Risk of venous thromboembolism in patients with cancer treated with Cisplatin: a systematic review and meta-analysis. J Clin Oncol 30(35):4416\u20134426. https:\/\/doi.org\/10.1200\/JCO.2012.42.4358","journal-title":"J Clin Oncol"},{"issue":"2","key":"4853_CR31","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41571-023-00844-0","volume":"21","author":"J LoPiccolo","year":"2024","unstructured":"LoPiccolo J, Gusev A, Christiani DC, Janne PA (2024) Lung cancer in patients who have never smoked - an emerging disease. Nat Rev Clin Oncol 21(2):121\u2013146. https:\/\/doi.org\/10.1038\/s41571-023-00844-0","journal-title":"Nat Rev Clin Oncol"},{"key":"4853_CR32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1146\/annurev.pharmtox.48.113006.094742","volume":"49","author":"NL Benowitz","year":"2009","unstructured":"Benowitz NL (2009) Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annu Rev Pharmacol Toxicol 49:57\u201371. https:\/\/doi.org\/10.1146\/annurev.pharmtox.48.113006.094742","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"4","key":"4853_CR33","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1001\/jamaoncol.2025.0001","volume":"11","author":"LL Michel","year":"2025","unstructured":"Michel LL, Schwarz D, Romar P et al (2025) Efficacy of hand cooling and compression in preventing taxane-induced neuropathy: the POLAR randomized clinical trial. JAMA Oncol 11(4):408\u2013415. https:\/\/doi.org\/10.1001\/jamaoncol.2025.0001","journal-title":"JAMA Oncol"},{"issue":"5","key":"4853_CR34","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1200\/JCO-24-02120","volume":"43","author":"VK Morris","year":"2025","unstructured":"Morris VK, Kennedy EB, Amin MA et al (2025) Systemic therapy for stage I-III anal squamous cell carcinoma: ASCO guideline. J Clin Oncol 43(5):605\u2013615. https:\/\/doi.org\/10.1200\/JCO-24-02120","journal-title":"J Clin Oncol"},{"key":"4853_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2025.107299","volume":"165","author":"MVN Barcelona","year":"2025","unstructured":"Barcelona MVN, Waldron J, Sullivan BO et al (2025) Outcomes following IMRT alone in head and neck squamous cell carcinoma ordinarily managed with concurrent chemo-radiotherapy. Oral Oncol 165:107299. https:\/\/doi.org\/10.1016\/j.oraloncology.2025.107299","journal-title":"Oral Oncol"},{"issue":"1","key":"4853_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.31389","volume":"72","author":"AD Trobaugh-Lotrario","year":"2025","unstructured":"Trobaugh-Lotrario AD, O\u2019Neill AF, Belmonte KA, Malogolowkin MH, Tiao GM, Geller JI (2025) Characteristics of patients with liver tumors deemed ineligible for enrollment on Children\u2019s Oncology Group trial AHEP1531: an opportunity to expand inclusion criteria and improve outcome. Pediatr Blood Cancer 72(1):e31389. https:\/\/doi.org\/10.1002\/pbc.31389","journal-title":"Pediatr Blood Cancer"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-025-04853-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-025-04853-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-025-04853-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T14:39:43Z","timestamp":1767710383000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00280-025-04853-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4853"],"URL":"https:\/\/doi.org\/10.1007\/s00280-025-04853-x","relation":{},"ISSN":["1432-0843"],"issn-type":[{"type":"electronic","value":"1432-0843"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"assertion":[{"value":"6 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Ethics Committee of Xiangya Hospital (approval number: 2023030637). The Declaration of Helsinki was adhered to in all protocols and procedures for human trials. The ethics committee waived the requirement for informed consent from patients because of the retrospective nature of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"As this was a retrospective study, the Ethics Committee of Xiangya Hospital has waived the requirement for obtaining informed consent from patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The paper was not considered by another journal. All authors met the criteria for authorship and agreed to publish.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"6"}}